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PML nuclear body disruption impairs DNA
double-strand break sensing and repair in APL
A di Masi*,1,2,7, D Cilli1,7, F Berardinelli1, A Talarico1, I Pallavicini3, R Pennisi1, S Leone1, A Antoccia1,2, NI Noguera4,5, F Lo-Coco4,5,
P Ascenzi1,2, S Minucci3 and C Nervi6
Proteins involved in DNA double-strand break (DSB) repair localize within the promyelocytic leukemia nuclear bodies (PML-NBs),
whose disruption is at the root of the acute promyelocytic leukemia (APL) pathogenesis. All-trans-retinoic acid (RA) treatment
induces PML-RARα degradation, restores PML-NB functions, and causes terminal cell differentiation of APL blasts. However, the
precise role of the APL-associated PML-RARα oncoprotein and PML-NB integrity in the DSB response in APL leukemogenesis and
tumor suppression is still lacking. Primary leukemia blasts isolated from APL patients showed high phosphorylation levels of H2AX
(γ-H2AX), an initial DSBs sensor. By addressing the consequences of ionizing radiation (IR)-induced DSB response in primary APL
blasts and RA-responsive and -resistant myeloid cell lines carrying endogenous or ectopically expressed PML-RARα, before and
after treatment with RA, we found that the disruption of PML-NBs is associated with delayed DSB response, as revealed by the
impaired kinetic of disappearance of γ-H2AX and 53BP1 foci and activation of ATM and of its substrates H2AX, NBN, and CHK2. The
disruption of PML-NB integrity by PML-RARα also affects the IR-induced DSB response in a preleukemic mouse model of APL in vivo.
We propose the oncoprotein-dependent PML-NB disruption and DDR impairment as relevant early events in APL tumorigenesis.
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The DNA damage response (DDR) includes cell cycle arrest
and transcriptional and post-translational activation of genes
involved in DNA repair and triggering of apoptosis. Deficien-
cies in DDR are fundamental to the etiology of most human
cancers.1
The DNA double-strand breaks (DSBs) arise from endo-
genous and exogenous sources, including replication
errors, chemical mutagens, and ionizing radiation (IR).2
The sensing phase of the DSB response includes their
recognition by the MRE11/RAD50/NBN complex, ATM protein
activation, histoneH2AX phosphorylation at Ser139 (γ-H2AX),
MDC1, and 53BP1 recruitment. γ-H2AX is an initial DSB
sensor for subsequent accumulation and post-translational
modification (PTM) of signaling and repair proteins to
form the so-called IR-induced foci (IRIF).3–8 Finally, DSBs
are removed through either the non-homologous end-joining
(NHEJ) or the homologous recombination repair (HRR)
pathways.9
Many proteins involved in the DDR localize within the
promyelocytic leukemia (PML)-nuclear bodies (PML-NBs).10–16
PML-NBs are nuclear organelles implicated in cellular
processes relevant to tumor suppression (e.g., PTM,
DDR, transcriptional regulation, induction of apoptosis, and
senescence).16–21 PML-NBs increase in number and change
their subnuclear distribution in response to DNA damage and
represent structures where protein complexes are assembled,
anchored, and/or post-translationally modified.11,13,15,16,22
PML also undergoes PTMs, SUMOylation representing one
of the main modification necessary for the proper NB
biogenesis and regulation of the cellular response to the DNA
damage.23
Aberrant levels of the PML protein and loss of PML-NBS
integrity were reported in acute promyelocytic leukemia (APL)
and in other tumors.24 PML gene was originally cloned in APL
leukemic cells carrying the t(15;17) detectable in over 95% of
APLs. This translocation involves the PML and the retinoic
acid receptor-α (RARα) genes, and generates the PML-RARα
fusion gene.25–27 PML-RARα acts as a transcriptional
repressor antagonizing myeloid differentiation and promoting
the self-renewal capacity of APL-initiating cells.28,29 PML-
RARα also competitively inhibits the oligomerization of wild-
type (WT) PML proteins, leading to the disruption of PML-NBs
into nuclear ‘microspeckles’.30 In APL cells, all-trans retinoic
acid (RA) treatment restores NB integrity, reverses PML-
RARα-mediated transcriptional inhibition, and induces PML-
RARα degradation and terminal cell differentiation.29,31,32
To date, it is yet unclear to what extent the DSBS repair is
dependent upon PML and PML-NBS function. Here, the
1Department of Science, Roma Tre University, Viale Guglielmo Marconi 446, Rome 00146, Italy; 2Istituto Nazionale di Biostrutture e Biosistemi, Viale Medaglie d’Oro 305,
Rome 00136, Italy; 3IFOM-IEO Campus, Via Adamello 16, Milan 20139, Italy; 4Department of Biomedicine and Prevention, University of Rome ‘Tor Vergata’, Rome, Italy;
5Neuro-Oncoematology Unit, Santa Lucia Foundation, Rome, Italy and 6Department of Medico-Surgical Sciences and Biotechnologies, University of Rome ‘La Sapienza’,
Corso della Repubblica 79, Latina 04100, Italy
*Corresponding author: A di Masi, Department of Science, Roma Tre University, Viale Guglielmo Marconi 446, Rome 00146, Italy. Tel: 39 06 57333621; Fax: 39 06
57336321; E-mail: alessandra.dimasi@uniroma3.it
7These two authors contributed equally to this work.
Received 15.3.16; accepted 28.3.16; Edited by G Raschellà
Abbreviations: APL, acute promyelocytic leukemia; DDR, DNA damage response; DSB, DNA double-strand break; IR, ionizing radiation; γ-H2AX, H2AX phosphorylation
at Ser139; HDACi, histone deacetylase inhibitor; HPC, hematopoietic progenitors; HRR, homologous recombination repair; IRIF, ionizing radiation-induced foci; mFISH,
multicolor FISH; NHEJ, non-homologous end-joining; PML, promyelocytic leukemia; PML-NB, PML nuclear body; PTM, post-translational modification; RA, all-trans
retinoic acid
Citation: Cell Death and Disease (2016) 7, e2308; doi:10.1038/cddis.2016.115
Official Journal of the Cell Death Differentiation Association
www.nature.com/cddis
relationship existing between PML-NBS integrity and
IR-induced DSBS sensing, signaling, and repair has been
investigated in leukemic cells derived from APL individuals,
myeloid cell lines expressing or not the PML-RARα and in a
PML-RARα preleukemic mouse model in vivo. Data obtained
show that the expression of PML-RARα in myeloid cells
causes basal damage and a defective DSBS response,
highlighting the pivotal role of PML-NBs in coordinating and
regulating the early and late events of DDR in APL. Overall,
our results suggest that PML-RARα-dependent PML-NBS
disruption and DDR impairment are relevant early events in
APL tumorigenesis.
Results
The integrity of PML-NBs is required for a proper DSBs
rejoining. Double immunofluorescence staining with anti-
PML and anti-γ-H2AX antibodies allowed the detection of
disassembled PML-NBs and high number of γ-H2AX foci in
primary blasts isolated at diagnosis from three APL patients,
harboring the chromosomal translocation t(15;17) resulting in
the PML-RARα fusion product (also confirmed by RT-PCR,
Figures 1a and b). Biological and clinical features of these
APL cases are reported in Supplementary Table S1. Similar
results were observed in the APL-derived NB4 cell line and in
its RA-resistant derived subclone NB4-MR4 (Figure 1a and
Supplementary Figure S1A).
The DSBs repair capability after 1 Gy of X-rays was
evaluated as mean value of γ-H2AX foci/cell and as
percentage of residual DSBs at each time point. In primary
APL blasts, the number of γ-H2AX foci reached a peak after
0.5 h from IR, and slowly decreased after 3 h (∼45 foci/cell and
80% of unrepaired DSBs). A high number of unrepaired DSBs
persisted after 24 h from IR, highlighting a delay in the DSBS
repair in APL blasts (∼12 foci/cell and 24% of unrepaired
DSBs) (Figures 1b and c).
Confocal microscopy also revealed a high number of γ-
H2AX foci/cell in the untreated NB4 and RA-resistant NB4-
MR4 cells (Figures 1 and b and Supplementary Figure S1).
The peak in the mean value of γ-H2AX foci/cell was reached at
0.5 h from IR in both RA-untreated and RA-treated cells. A
significant difference in the mean value of γ-H2AX foci/cell and
in the percentage of residual DSBs was observed after 3 h
from IR (~80% of unrepaired DSBs in NB4, NB4-MR4, and
RA-treated NB4-MR4 cells; ~ 60% of unrepaired DSBs in RA-
treated NB4 cells; Po0.05; Figures 1b and c). Similar to APL
blasts, the DSB rejoining profile in NB4 cells showed that at
24–48 h from IR the number of persisting DSBs was
significantly higher in NB4 cells and in NB4-MR4 cells, than
in RA-treated NB4 cells (Figures 1b and c). In these cells PML-
NBs were restored following PML-RARα degradation and
granulopoiesis was induced in a time-dependent and IR-
independent manner, as revealed by an increased expression
of he myeloid differentiation marker CD11b (Supplementary
Figures S1B and C).
By immunoblot analysis we further observed that γ-H2AX
was undetectable or barely detectable in human CD34+
hematopoietic progenitor cells (HPCs) and CD34− mono-
nuclear cells (MNCs), respectively, whereas high levels of γ-
H2AX were observed in PML-RARα-expressing samples from
three APL patients, as well as in NB4 and NB4-MR4 cells
(Figure 2a). RA treatment in NB4 cells decreased the levels of
γ-H2AX when compared with untreated cells. Following IR, in
NB4 cells the highest levels of γ-H2AX were detectable after
3 h, persisting until 24 h, whereas in RA-treated cells γ-H2AX
levels reached a peak at 0.5 h and gradually decreased until
24 h (Figure 2b). IR treatment did not exert any effect on RARα
or PML-RARα expression levels in primary APL blasts and
NB4 cells (Figure 2c).
IR-treated U937/PR9 cells induced to express the PML-
RARα oncoprotein by ZnSO4 provided results similar to those
observed in APL blasts and NB4 cells. U937/PR9+ZnSO4
cells displayed ~ 80%, 20%, and 10% of persisting DSBs after
3, 24, and 48 h from IR, respectively (Figures 2d and e). After
RA treatment in U937/PR9+ZnSO4 cells, resulting in PML/
RARα degradation and PML-NBS reformation, the percentage
of persisting DSBs was 60%, 10%, and 2% after 3, 24, and
48 h, respectively. Interestingly, similar γ-H2AX foci/cell mean
values and DSBS rejoining profiles were measurable, before
or after treatment with ZnSO4 and/or RA, in myeloid cell lines
expressing the WT PML protein such as U937/MT, U937/WT,
HL60, and HL60-R, a RA-resistant subclone of HL60
(Figures 2d and e and Supplementary Figures S2A–C). Of
note, the IR treatment did not exert any effect on RARα or
PML-RARα expression levels in U937/PR9 andU937/MT cells
(Figure 2c). This further suggested a role for the PML-NB
disruption following PML-RARα expression in the DSB
rejoining proficiency of myeloid cells.
The integrity of PML-NBs is required for the recruitment
of 53BP1 to the DSBs. 53BP1 accumulates within the PML-
NBs and is recruited into IRIF after DSBS induction,
promoting the activation of the repair signaling.33 Therefore,
we studied the DSB kinetics by counting the number of
53BP1 foci in primary APL cells and NB4 and NB4-MR4 cells
after 0.5, 3, and 24 h from irradiation with 1 Gy. We found that
PML-NBS integrity is required for 53BP1 localization into the
nuclei and for 53BP1 foci formation after DSBS induction. In
fact, 53BP1 was barely detectable in non-irradiated APL
blasts and NB4 cells, probably because of a weak basal
expression of 53BP1 or of its pan-nuclear dispersion into the
disassembled PML-NBs. On the contrary, 53BP1 colocalized
with PML within the restored PML-NBs following RA
treatment of NB4 cells (Figure 3a). After IR-induced damage,
the 53BP1 foci number and colocalization with PML was
significantly lower in RA-untreated APL blasts and NB4 and
NB4-MR4 cells compared with RA-treated NB4 cells
(Figures 3a–c). Thus, restoration of the 53BP1 foci within
the reformed PML-NBs may occur as a consequence of the
RA-induced PML-RARα degradation.
We evaluated the DSBs rejoining efficiency in cells
expressing the PML-RARα oncoprotein and in cells expres-
sing the WT PML by counting the number of 53BP1 foci/cell in
untreated and irradiated cells (Figures 3b and d and
Supplementary Figure S2D). After 0.5 h from IR, APL blasts
and NB4 cells showedmean numbers of 53BP1 foci/cell lower
than those calculated in cells expressing WT PML or in cells
where PML-RARα was degraded by RA. After 3 h from IR, APL
blasts and NB4 cells showed a number of 53BP1 foci
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significantly higher than that measurable in cells expressingWT
PML or where the PML-RARα was degraded by RA. Finally,
after 24 and 48 h from IR, the residual mean value of 53BP1 foci/
cell scored in cells expressing thePML-RARα fusion proteinwas
significantly higher compared with those expressing WT PML
(Figures 3b and d and Supplementary Figure S2D).
PML-RARα does not increase chromosomal in stability,
S phase, and cell death. To evaluate whether the residual
γ-H2AX and 53BP1 foci/cell observed after 24 and 48 h from
IR in APL blasts and PML-RARα-expressing cells may
correlate with chromosome instability, the multicolor FISH
(mFISH) analysis was performed in NB4 cells, either
untreated or exposed to RA, in combination with exposure
to 1 Gy. The karyotype of NB4 was established considering
conserved translocations that appear in 490% of the cells
analyzed in controls. Karyotype was hypotetraploid and can
be summarized as follows: 80 XX, −X, −X, − 1, −3, − 5, +7,
Figure 1 PML-NB integrity and γ-H2AX dephosphorylation kinetics. (a) Representative images of the double immunofluorescence analysis of γ-H2AX (Alexa Fluor 488, green
fluorophore) and PML (Alexa Fluor 610, red fluorophore) foci in APL blasts untreated (Ctrl) and exposed to 1 Gy of X-rays and fixed after 0.5, 3, and 24 h (cell image: bright field;
confocal microscopy images, magnification × 63), and NB4 cells treated or not with 1 μMRA for 72 h, and then exposed to IR and fixed after 0.5, 3, 24, and 48 h (counterstain: DAPI;
confocal microscopy images, magnification × 63). (b) Quantification of the mean number of γ-H2AX foci/cell and (c) analysis of the rejoining capability measured as percentage of
DSBs in untreated and irradiated APL blasts derived from 3 different individuals, and NB4 and NB4-MR4 cells untreated or treated with 1 μM RA for 72 h and then irradiated with 1
Gy. For NB4 and NB4-MR4 DSB rejoining graphs; * and ** indicate significant differences of RA-treated NB4 cells with respect to RA-untreated NB4 cells and NB4-MR4 cells. Mean
values were derived from the analysis of 100 cells in 3 independent experiments±S.D. For DSBs, the mean number of γ-H2AX foci/cell measurable at 0.5 h after IR was taken as
100%. *Po0.05; **Po0.01. Confocal analysis was performed using the LCS Leica confocal microscope (Leica Microsystems, Heidelberg, Germany)
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−8, −14, −15, −18, − 19, − 19, −19, −19, −21, − 22, t(8′–
9), (9′–8), t(10–19), t(10–19), t(14–19), t(15′–17), t(16–5)
t(17′–15), t(17′–15) (Figures 4a and b). The analysis of
chromosomal exchanges in each sample was performed
ignoring basal translocations observed in control cells.
Results obtained indicated that RA alone did not exert any
effect on the frequency of chromosome aberrations over
control values and did not modify IR-induced break frequency
(Figure 4b). Although break frequency remain unchanged,
RA pretreatment reduced the frequency of IR-induced
chromosome exchanges (from 2 to 0.9 exchanges/cell in
NB4 control and RA-treated irradiated samples, respectively),
whereas it increased the frequency of chromosomal excess
fragments (from 1.8 to 3.9 fragments/cells in NB4 control and
RA-treated irradiated samples, respectively) (Figure 4b). The
only difference observed in RA-treated versus untreated NB4
samples was in terms of quality of the IR-induced chromo-
some damage rather than in terms of quantity (total breaks).
Unfortunately, cytogenetic analysis could not be performed
on primary APL samples because of the very slow prolifera-
tion rate of blasts isolated from the peripheral blood that are
blocked in the G0/G1 phase of the cell cycle (Figure 4c).
As H2AX is phosphorylated either during the S phase of the
cell cycle or as a consequence of cell death induction,34 we
analyzed the cell cycle profile and the sub-G1 population of
APL blasts andmyeloid cell lines. In APL blasts,490%of cells
were in G1, 2% in S and 8% in G2/M phases of the cell cycle
(Figure 4c), whereas the sub-G1 population was ~ 4%
Figure 2 (a) Representative immunoblot analysis of H2AX and H2AX phosphorylation at the Ser139 residue in untreated human CD34− and CD34+ cells isolated from the
peripheral blood of normal donors, in three APL patients, in NB4 and NB4-MR4 cells. (b) Representative immunoblot analysis of H2AX phosphorylation in NB4 cells treated or not
with 1 μM RA for 72 h and then irradiated with 1 Gy of X-rays and lysed after 0.5, 3, and 24 h. (c) Representative immunoblot analysis of RARα and PML-RARα expression levels
in APL blasts, NB4, U937/PR9, and U937/MT cells exposed to IR and lysed after 0.5 h; before irradiation, NB4 cells were treated or not with 1 μMRA for 72 h, whereas U937/PR9
cells were treated or not with 100 μM ZnSO4 for 8 h and then with 1 μM RA for 72 h, as indicated; filters were probed with anti-RARα antibody, and tubulin was used as loading
control. (d) Quantification of the mean number of γ-H2AX foci/cell and (e) analysis of the rejoining capability measured as percentage of DSBs in U937/PR9, U937/MT, and U937/
WT cells treated or not with 100 μM ZnSO4 for 8 h and/or with 1 μM RA for 72 h, as indicated; cells were then exposed to IR and fixed at the indicated times. Mean values were
derived from the analysis of 100 cells in three independent experiments± S.D. For DSBs, the mean number of γ-H2AX foci/cell measurable at 0.5 h after IR was taken as 100%.
**Po0.01. For U937/PR9 DSB rejoining graph; **indicates significant differences of ZnSO4-treated U937/PR9 cells with respect to U937/PR9 control cells. Confocal analysis was
performed using the LCS Leica confocal microscope (Leica Microsystems)
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(Figure 4e). Cell cycle analysis in NB4 and U937/PR9 cells
treated or not with RA and ZnSO4, respectively, untreated or
irradiated with 1 Gy, showed that the high number of γ-H2AX
foci/cell scored in PML-RARα-expressing cells did not
correlate with the percentage of cells in the S phase
(Figures 4c and d). Moreover, in NB4 and U937/PR9 cells,
no association was observed between the number of γ-H2AX
foci/cell and cell death, both in basal conditions and after 24 h
from IR exposure (Figures 4e and f). Overall, data obtained
indicated that the high basal levels of γ-H2AX foci observed in
APL blasts and PML-RARα-expressing cells are not asso-
ciated with the cell cycle S-phase or with cell death.
The integrity of PML-NBs is required for ATM activation.
ATM kinase, a critical regulator of the DDR, is rapidly
phosphorylated at the Ser1981 residue in response to IR,
and its active form in turn phosphorylates H2AX at Ser139,
as well as several other component of the DDR (e.g., NBN at
Ser 343 and CHK2 at Thr68).2 We evaluated the role of
PML-NBS integrity in ATM phosphorylation at Ser1981 and
Figure 3 PML-NB integrity and 53BP1 recruitment to the DSBs. (a) Representative images of 53BP1 foci disappearance in APL blasts untreated (Ctrl) and exposed to 1 Gy
and fixed after 0.5, 3, and 24 h, and in RA-untreated (NB4) and RA-treated (NB4+RA) cells non-irradiated (Ctrl) and exposed to IR and fixed after 0.5 h (cell image: bright field;
confocal microscopy images, magnification × 63; 53BP1 (Alexa Fluor 488, green fluorophore); PML (Alexa Fluor 610, red fluorophore)). (b) Quantification of 53BP1 foci/cell,
reported as the mean value of 53BP1 foci in APL blasts, NB4 and NB4-MR4 cells untreated or treated with 1 μM RA for 72 h, and U937/PR9 cells either untreated or exposed for
8 h to 100 μM ZnSO4 and then treated or not with 1 μM RA for 72 h. After ZnSO4 and/or RA treatment, cells were irradiated with 1 Gy and fixed at the indicated time points. (c)
Quantification of 53BP1 foci association events with PML per nucleus in APL blasts, NB4, NB4-MR4, and U937/PR9 cells. (d) Quantification of 53BP1 foci/cell and 53BP1 foci
association events with PML per nucleus in U937/MT cells. Before irradiation, U937/MT cells were either untreated or exposed for 8 h to 100 μM ZnSO4 and then treated or not
with 1 μM RA for 72 h. Mean values were derived from the analysis of 100 cells in three independent experiments± S.D. *Po0.05; **Po0.01. Confocal analysis was performed
using the LCS Leica confocal microscope (Leica Microsystems)
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activation in response to IR. ATM resulted poorly activated in
non-irradiated PML-RARα-expressing APL blasts, its
Ser1981-phosphorylated form colocalizing with PML at 3 h
from the irradiation with 1 Gy (Figure 5a). Similar to primary
APL blasts, pSer1981-ATM foci were barely detectable in
non-irradiated NB4 and U937/PR9+ZnSO4 cells (Figures 5b
and c). In PML-RARα-expressing cells, ATM activation and
colocalization with PML was well detectable after 3 h from IR,
whereas in cells expressing the WT PML (i.e., U937/WT and
U937/PR9) an accumulation of pSer1981-ATM in PML foci
was already visible after 0.5 h from IR (Figure 5c and
Supplementary Figure S3A). Interestingly, RA treatment in
both NB4 cells and Zn-induced U937/PR9 restored the
pSer1981-ATM/PML colocalization pattern into PML-NBs
after 0.5 h from IR (Figures 5b and c).
The integrity of PML-NBs is required for DSBS signal
transduction. Co-immunofluorescence experiments with
anti-pSer1981-ATM and anti-pSer343-NBN antibodies indi-
cated that ATM and NBN phosphorylation were significantly
induced after 3 h from irradiation with 1 Gy in PML-RARα-
expressing cells (Figure 6). In PML-RARα cells treated with
RA (NB4+RA and Zn-induced U937/PR9+RA) and in cells
expressing the WT PML (U937/WT and U937/PR9 cells), a
high number of pSer1981-ATM foci, colocalizing with
pSer343-NBN, was visible at 0.5 h from IR; at 3 h from IR,
pSer1981-ATM foci disappeared whereas NBN foci persisted
(Figures 6b and c and Supplementary Figure S3B). These
findings are in agreement with the proposed function of NBN
in several phases of the DDR.35,36
Figure 4 Chromosomal damage, cell cycle distribution, and apoptosis in PML-RARα-expressing cells. (a) Representative image of an mFISH-stained NB4 karyotype.
Karyotype was established considering conserved translocations that appear in490% of the cells analyzed in controls. Metaphases were captured with the Axio Imager M1
microscope (Carl Zeiss, Oberkochen, Germany). Karyotyping and cytogenetic analysis of each single chromosome was performed by the ISIS software. (b) Frequency per cell of
chromosomal aberrations (i.e., fragments, exchanges, and breaks) after irradiation with 1 Gy in NB4 cells untreated or exposed to 1 μM RA for 72 h. (c) Cell cycle distribution of
APL blasts and of NB4 cells untreated or treated with 1 μM RA for 72 h and then irradiated and fixed after 24 h. (d) Cell cycle distribution of U937/PR9 cells untreated or treated
with 100 μM ZnSO4 for 8 h to induce PML-RARα expression and then irradiated and fixed after 24 h. (e) Sub-G1 population analyzed by flow cytometry in APL blasts and in NB4
cells untreated or treated with 1 μMRA for 72 h, and then irradiated and fixed after 24 h. (f) Sub- G1 population analyzed by flow cytometry in U937/PR9 cells untreated or treated
with 100 μM ZnSO4 for 8 h, and then irradiated and fixed after 24 h. Mean values were derived from three independent experiments± S.D. **Po0.01
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Immunoblot analysis further showed that in PML-RARα-
expressing cells, ATM, NBN, and CHK2 proteins were
phosphorylated in response to IR although with a delayed
kinetics (Figure 7a). Indeed, the phosphorylation signal of
ATM, NBN, and CHK2 reached a peak after 3 h from IR, ATM
phosphorylation being visible up to 24 h from irradiation
(Figures 7a and b), whereas in cells expressing WT PML,
the ATM, NBN, and CHK2 proteins were phosphorylated after
0.5 h from IR, the phosphorylation signal being strongly
reduced after 3 and 24 h (Figures 7a and b and
Supplementary Figure S4A). These data indicate that PML-
NBS integrity is necessary for a correct ATM–CHK2 axis
Figure 5 PML-NB integrity and ATM activation. Double immunofluorescence of pSer1981-ATM (Alexa Fluor 488, green fluorophore) and PML (Alexa Fluor 610, red
fluorophore) foci performed in cells untreated or irradiated with 1 Gy and fixed after 0.5 and 3 h. Representative images of the analysis performed in (a) APL blasts (cell image:
bright field), (b) NB4 cells untreated or treated with 1 μM RA for 72 h previous to IR (counterstain: DAPI), and (c) U937/PR9 cells either untreated or exposed for 8 h to 100 μM
ZnSO4 and then untreated or treated with 1 μMRA for 72 h previous to IR (counterstain: DAPI). Some colocalization signals have been highlighted and marked within the cell by a
white square. Confocal microscopy images, magnification × 63; LCS Leica confocal microscope (Leica Microsystems)
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Figure 6 PML-NB integrity and ATM-dependent NBN phosphorylation. Double immunofluorescence of pSer1981-ATM (Alexa Fluor 488, green fluorophore) and pSer343-
NBN (Alexa Fluor 610, red fluorophore) foci performed in cells untreated or irradiated with 1 Gy and fixed after 0.5 and 3 h. Representative images of the analysis performed in (a)
APL blasts (cell image: bright field), (b) NB4 cells untreated or treated with 1 μM RA for 72 h previous to IR (counterstain: DAPI), and (c) U937/PR9 cells either untreated or
exposed for 8 h to 100 μM ZnSO4 and then treated or not with 1 μM RA for 72 h previous to IR (counterstain: DAPI). Some colocalization signals have been highlighted and
marked within the cell by a white square. Confocal microscopy images, magnification × 63; LCS Leica confocal microscope (Leica Microsystems)
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activation.22 Furthermore, immunoblot analysis showed that
H2AX, NBN, and CHK2 expression and phosphorylation
levels were not affected in U937/PR9 cells treated or not with
ZnSO4, then exposed to cycloheximide and finally irradiated,
thus suggesting that de novo protein synthesis is not involved
in the DDR signaling defects detected in APL cells (Figure 7c).
Defective DSBS sensing and repair in a preleukemic
mouse model of APL. To evaluate the role of PML-RARα
expression in the DSBS sensing and signaling in vivo, we
used the preleukemic model of APL (i.e., PR mice).37 In this
model, the disease develops after a long latency, suggesting
that additional alterations cooperate with PML-RARα for
leukemia development. We confirmed that in Lin− HPCs from
these mice the expression levels of RARα and PML-RARα
were not affected by IR. Of note, the levels of γ-H2AX were
higher in untreated PR as compared with WT mice
(Figures 8a and b).
PR mice HPCs showed a microsplecked nuclear pattern of
PML-NBs whose number increased after irradiation with 5.5
Gy (Figure 8b). Kinetics of both γ-H2AX dephosphorylation
and 53BP1 recruitment at the DSBs were delayed in
preleukemic PR mice as compared with WT animals, with
the persistence of significantly higher levels of unrepaired
damage after 24 h from IR (Po0.05; Figures 8b–d). In
addition, the ATM activation, as well as the phosphorylation
of its substrates NBN and CHK2, was delayed in PR mice as
compared with WT mice (Figures 8e and f). To analyze the
DSBS repair pathway active in WTand PR mice, we looked at
the status of the DNA-PK and RAD51 that play key roles in the
NHEJ repair and HRR, respectively.9 Results showed that
DNA-PK was not phosphorylated following IR either in WTor
PRmice, whereas RAD51 was induced at 3 h in irradiatedWT
mice (Figure 8f). These results suggested that PML-RARα
expression impairs the IR-induced activation of HRR in vivo.
Discussion
Disruption of PML-NBs by PML-RARα is a hallmark of APL, a
model disease to understand leukemogenic pathways direc-
ted by an oncoprotein.24–32 Here, we report that PML-NBs play
a key role in regulating early and late steps of IR-induced
DSBs sensing, signaling, and repair in myeloid cells in vitro
and in vivo. These events may depend on the cellular context
as PML depletion/overexpression and PML-RARα ectopic
expression in non-hematopoietic cells and solid tumors only
impairs the late phases of HRR.16
Results obtained in a PML-RARα preleukemic knock-in
mouse model strongly suggest that the PML-RARα-induced
PML-NBs disruption is associated with DDR impairment and
represents an early event in APL pathogenesis. Evidence
obtained inmyeloid cells expressing or not the PML-RARα and
in RA-resistant myeloid cells lines suggested that RA-induced
reformation of PML-NBs and oncoprotein degradation, two
events contributing to the therapeutic effect of RA in APL, is
tightly correlated with the restoration of DDR in APL cells.
Moreover, our results point to a direct involvement of RA
binding to the endogenous PML-RARα in the restoration of
PML-NB integrity and DDR.
In agreement with previous findings obtained in APL cell lines
and in hematopoietic precursors from mice expressing PML-
RARα,14,38 we showed that primary APL blasts and
Lin− HPCs from PR mice were characterized by higher levels
of γ-H2AX than those detectable in normal human and murine
HPCs. Interestingly, high levels of γ-H2AX foci were found
in human tumors and cultured cells,39 during the S phase of the
cell cycle, and during apoptosis.34 The cell cycle analysis in
APL blasts and in PML-RARα-expressing cells seems to
exclude the possibility that H2AX phosphorylation depends
on the percentage of cells in the S phase or on apoptotic events.
Interestingly, PML-RARα expression increases the capability of
Figure 7 Phosphorylation of ATM kinase and its substrates in PML-RARα-expressing cells. (a) Immunoblot analysis of pSer1981-ATM, pSer343-NBN, and pThr68-CHK2
phosphorylation in APL blasts, NB4, NB4-MR4, and U937/PR9 cells. Previous to IR, NB4 and NB4-MR4 cells were either untreated or exposed to 1 μM RA for 72 h, whereas
U937/PR9 cells were either untreated or exposed for 8 h to 100 μM ZnSO4, and then treated or not with 1 μM RA for 72 h. Cells were then exposed to 1 Gy of X-rays and lysed
after 0.5, 3, and 24 h. (b) Immunoblot analysis of ATM phosphorylation at the Ser1981 residue after 24 h from IR in NB4 and U937/PR9 cells. (c) U937/PR9 cells were first treated
with 100 μM of ZnSO4, then exposed to 10 μg/ml cycloheximide, and finally irradiated with 1 Gy and lysed after 0.5 h. Immunoblots were performed using anti-γ-H2AX, anti-
pSer343-NBN, anti-NBN, anti-pThr68-CHK2, and anti-CHK2 antibodies. Blots presented are exemplificative of the results obtained from two independent experiments
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histone deacetylase inhibitors (HDACi) to induce DNA damage
and apoptosis by affecting the expression of genes involved in
DNA repairmechanism.38 ThismayexplainHDACi selectivity in
causing cancer cell death in certain transformed cells.40
As γ-H2AX represents a biomarker of the DSB, but not a
functional component of theDDR,2–4 we further analyzedDSBS
sensing using 53BP1, a protein that accumulates within PML-
NBs and is involved in DSBs repair.41,42 The time-course
analysis of 53BP1 recruitment at the DSBs in in vitro and in vivo
models of APL indicated that the disruption of the PML-NBs
slows its recruitment at the DSBs after IR. 53BP1 was
nonrandomly associated with PML-NBs and its distribution
within the nucleus was dependent on PML-NBs integrity.
Furthermore, we observed that in myeloid cells the number of
PML nuclear bodies and DSB repair in APL
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53BP1 and PML associations follows the DSBs rejoining
profile, indicating an association of the two proteins at the
DSB foci in vivo. Indeed, a defective recruitment of 53BP1 to the
damaged sites was observed in PML-RARα-expressing cells,
the proper localization being re-established by RA treatment.
Overall, our findings suggest that the expression of the
PML-RARα fusion protein, by destroying the PML-NBS
integrity, slows down the DSBS rejoining kinetics in human
APL blasts and cell lines, and in hematopoietic progenitors
from the APL mouse model. This may contribute to the
persistence of the higher number of γ-H2AX and 53BP1 foci at
longer times from IR in APL cells (when compared with
myeloid progenitors expressing normal PML protein and
PML-NBs), resembling the deficiency in the repair of specific
subset of DSBs described in DDR-defective cells.43 As PML-
NBs are defined as baskets that contain proteins involved in
the DSBS response, their disruption may cause a pan-nuclear
dispersion of DDR proteins and consequently a defect in the
DSBS tethering.10,11,13,15,16,44
The disruption of the PML-NBs by PML-RARα expression
does not increase the chromosomal instability in NB4 cells
treated or not with RA and/or IR, although a compromised
ability to maintain a genomic stability has been suggested as
part of APL pathogenesis.16 Most of the somatic events in APL
genomes appear to be random background mutations in the
hematopoietic cells that acquired the PML-RARα initiating
event.45,46 A broad spectrum of acquired and recurrent
chromosomal abnormalities, which may act as secondary
events and could explain APL leukemogenesis, were reported
by high-resolution single-nucleotide polymorphism array
(SNP-A) analysis in ~ 50% matched diagnosis and remission
samples from 48 APL cases. These genetic abnormalities
were undetectable by conventional cytogenetics.47 Almost
90% of these lesions were not exclusive of APL, but recurrent
in non-APL acute myeloid leukemias and other hematologic
neoplasms.47–50 Notably, mutations present in human leuke-
mias were also identified by the sequencing of an APL mouse
genome.51 Therefore, the PML-RARα initiating event may be
necessary, but not sufficient, to cause APL; additional hits,
largely unknown and possibly associated with the HPCs
impaired capability to properly repair the DNA lesions,52 may
occur and ultimately lead to the clonal expansion of leukemic
blasts.
PTMs regulate multiple biological functions of PML and
of PML-NBS disassembly and rebuilding during the DDR,21
and in turn PML-NBs regulate the PTMs of nuclear proteins
dependent upon the ATM and ATR kinases.11–13,53 In this
context, our results suggest the existence of a feedback
mechanism between PML-NBs and the ATM–NBN–CHK2
axis in the DSBS response. Beside a direct role of these
proteins in modulating PML-NB roles in the IR-induced DSBS
response,11 PML-NBS integrity may be necessary to rapidly
activate the DSBS sensing, signaling, and repair. Our results
highlight that PML-NBS disruption by PML-RARα strongly
affects ATM activation, as well as CHK2 and NBN phosphor-
ylation. This suggests that the PML-NBs integrity is necessary
to properly sense DSBs in order to activate ATM and to allow
ATM-dependent phosphorylation of proteins localized within
PML-NBs.11,12,52 The delayed recruitment of 53BP1 at the
DSBs in PML-RARα-expressing cells, harboring disrupted
PML-NBs, together with the impaired increase of RAD51
levels in PR mice, suggest that the HRR mechanism is
facilitated by intact PML-NBs in vivo.
Data here obtained in human primary APL blasts and in
myeloid cells, further confirmed in a preleukemicmousemodel
of APL, highlighted the relevant role of PML-NBs in coordinat-
ing and regulating the DDR. These results further shed light on
the events occurring at the onset of APL, suggesting that the
expression of PML-RARα disrupts PML-NBs, causes DNA
damage, and is responsible for a defect in the early and late
steps of the DDR that in turn play a role in the pathogenesis
and progression of APL.
Materials and Methods
Reagents and antibodies. The complete list of reagents and antibodies is
reported in Supplementary Materials and Methods.
Human samples, cell lines, and cultures. Leukemic cells were isolated
from the peripheral blood of three consenting, newly diagnosed APL individuals
presenting 480% circulating blasts and classified as M3 or M3v by morphological
criteria according to the French–American–British (FAB) classification. The main
biologic and clinical features of patients are summarized in Supplementary Table S1.
Analysis of the PML-RARα fusion gene was performed by RT-PCR as reported
elsewhere.54 CD34+ HPCs and mononuclear CD34+ cell fractions were isolated from
the peripheral blood of informed healthy donors according to institutional guidelines as
previously reported.55 Flow cytometric analysis confirmed that 490% of the cells
were CD34+.
The human myeloid leukemia cell lines were: the APL-derived NB4 cell line
containing the t(15;17)56 and the RA-resistant NB4-MR4 subclone;57 the human
promonocytic U937 cell line either WT (U937/WT) or carrying the PML-RARα
sequence under the control of the zinc-inducible MT-I promoter (U937/PR9) or an empty
MT1 vector (U937/MT);58 the human myeloblastic leukemia cell line HL60 and the RA-
resistant HL60-R subclone.59 NB4-MR4 and HL60-R resistant cell lines carry mutations
abrogating RA-binding capacities of PML-RARα and RARα, respectively. Cell culture
conditions and treatments are reported in Supplementary Materials and Methods.
APL murine model. Experiments were performed using a previously
described APL knock-in mouse model37 in accordance with the national and
international laws and policies. Experimental details are described in
Supplementary Materials and Methods.
Figure 8 In vivo validation of the DDR in the preleukemic mouse model of APL. WTand preleukemic mice knock-in for PML-RARα (PR) were irradiated with 5.5 Gy of X-rays
and sacrificied after 0.5, 3, 6, and 24 h. Lin− cells were isolated from the bone marrow of three pooled mice. (a) Immunoblot analysis of RARα and PML-RARα expression, and
of H2AX phosphorylation at Ser139 residue, in untreated and irradiated WT and PR mice. (b) Representative images of the double immunofluorescence analysis of γ-H2AX
(Alexa Fluor 488, green fluorophore) and PML (Alexa Fluor 610, red fluorophore) foci in untreated and irradiated WTand PR mice. (c) Representative images of the 53BP1 foci in
untreated and irradiated WT and PR mice. (d) The DSBs rejoining analysis was reported as the mean value of γ-H2AX foci/cell and as the percentage of residual DSBs in
untreated and irradiated WTand PR mice. The DSBS repair was also analyzed by counting the number of 53BP1 foci/cell in untreated and irradiated WTand PR mice. Mean
values were derived from the analysis of 100 cells from three independent experiments± S.D. *Po0.05, **Po0.01. (e) Representative images of the double
immunofluorescence analysis of pSer1981-ATM (Alexa Fluor 488, green fluorophore) and pSer343-NBN (Alexa Fluor 610, red fluorophore) foci in WT and PR mice. (f)
Immunoblot analysis of ATM phosphorylation at the Ser1981 residue, NBN phosphorylation at Ser343, CHK2 phosphorylation at Thr68, DNA-PK phosphorylation at Ser2056, and
RAD51 expression. Cell image: bright field; confocal microscopy images, magnification × 63; LCS Leica confocal microscope (Leica Microsystems)
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Analysis of cell cycle, differentiation, and apoptosis. Cell cycle, cell
differentiation, and apoptosis were analyzed with a Dako Galaxy Flow Cytometer (Dako
Denmark A/S, Glostrup, Denmark) equipped with a 488 nm laser source and with the
FloMax software (version 2.4e; Partec GmbH, Munster, Germany). Hypodiploid peak
analysis was performed as previously described.60 Cell differentiation was evaluated by
direct immunofluorescence staining using fluorochrome-conjugated anti-CD11b
antibody.14,32 Details are in Supplementary Materials and Methods.
Immunofluorescence analysis. Cells were seeded on a glass coverslip using
the Shandon Cytospin III (Thermo Fisher Scientific Inc., Waltham, MA, USA), and then
fixed, stained, and analyzed as described in Supplementary Materials and Methods.
Multicolor FISH. The mFISH was performed by hybridizing chromosome
spreads with the 21 × mFISH Probe Kit (MetaSystems, Altlussheim, Germany) as
described elsewhere.41 Karyotyping and cytogenetic analysis of each single
chromosome was performed by the ISIS software (MetaSystems, Altlussheim,
Germany). Detailed procedures are in Supplementary Materials and Methods.
Immunoblotting. Protein extraction and western blot analysis were performed
by standard procedures reported in Supplementary Materials and Methods.
Statistical analysis. Results are shown as the mean±S.D. derived minimally
from three independent experiments. Statistical significance between means was
assessed by Student’s t-test (GraphPad Software Inc., San Diego, CA, USA).
Statistical significance was considered as P-values of o0.05.
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